Yes Rowdy................same situation with Resmed and may others........RMD was recommended as a buy/strong buy by every broker report I've seen on it...........all the way from $12 to $4.40 just recently. Just illustrates that most research houses should get a technical analyst who knows their stuff and that their methods (DCF etc........) often leave a lot to be desired.
Takes another hammering, page-4
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$280.64 |
Change
-0.280(0.10%) |
Mkt cap ! $135.3B | |||
| Open | High | Low | Value | Volume |
| $281.47 | $282.13 | $279.80 | $103.2M | 368.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 972 | $280.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $280.75 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 27/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$280.71 |
Change
-0.280 ( 0.03 %) |
||||
| Open | High | Low | Volume | ||
| $281.55 | $282.17 | $279.85 | 53497 | ||
| Last updated 15.59pm 27/05/2024 ? | |||||
| CSL (ASX) Chart |